Nila Kartika Wati

Arrowhead Pharmaceuticals’ Plozasiran Scores Major Win in Phase 3 Trials, Signaling Potential Market Shift

• Treatment Innovations

Arrowhead Pharmaceuticals’ Plozasiran Scores Major Win in Phase 3 Trials, Signaling Potential Market Shift

Nila Kartika Wati July 22, 2026

In a significant advancement for genetic medicine, Arrowhead Pharmaceuticals has announced resounding success in two late-stage clinical...

Read More Read more about Arrowhead Pharmaceuticals’ Plozasiran Scores Major Win in Phase 3 Trials, Signaling Potential Market Shift

Four Years of 988: Assessing the Impact and Future of America’s Crisis Lifeline

• Breast Cancer Legislation and Policy

Four Years of 988: Assessing the Impact and Future of America’s Crisis Lifeline

Nila Kartika Wati July 22, 2026

Since its inception on July 16, 2022, the 988 Suicide & Crisis Lifeline has evolved from a...

Read More Read more about Four Years of 988: Assessing the Impact and Future of America’s Crisis Lifeline

Navigating the Invisible Weight: Addressing the Mental Health Crisis Among Previvors

• Survivorship and Post-Treatment

Navigating the Invisible Weight: Addressing the Mental Health Crisis Among Previvors

Nila Kartika Wati July 22, 2026

By Editorial Staff June 30, 2026 The term "previvor"—a portmanteau of "preventive" and "survivor"—has entered the modern...

Read More Read more about Navigating the Invisible Weight: Addressing the Mental Health Crisis Among Previvors

Global Health Visionaries Honoured: Celebrating Excellence at the 79th World Health Assembly

• Global Breast Cancer Awareness

Global Health Visionaries Honoured: Celebrating Excellence at the 79th World Health Assembly

Nila Kartika Wati July 21, 2026

GENEVA – The global health community gathered in Geneva this week as the 79th World Health Assembly...

Read More Read more about Global Health Visionaries Honoured: Celebrating Excellence at the 79th World Health Assembly

Groundbreaking Research Reveals Age-Related Blood Cell Mutations Infiltrate Tumours, Worsening Cancer Outcomes

• Medical Research and Clinical Trials

Groundbreaking Research Reveals Age-Related Blood Cell Mutations Infiltrate Tumours, Worsening Cancer Outcomes

Nila Kartika Wati July 20, 2026

London, UK – In a significant stride towards understanding the complex interplay between ageing and cancer, an...

Read More Read more about Groundbreaking Research Reveals Age-Related Blood Cell Mutations Infiltrate Tumours, Worsening Cancer Outcomes

Beyond the Pink Ribbon: Men’s Breast Cancer – A Story of Vigilance and Hope

• Patient Advocacy and Support

Beyond the Pink Ribbon: Men’s Breast Cancer – A Story of Vigilance and Hope

Nila Kartika Wati July 18, 2026

Introduction: Unveiling a Less-Discussed Reality Breast cancer, a disease overwhelmingly associated with women, casts a long shadow...

Read More Read more about Beyond the Pink Ribbon: Men’s Breast Cancer – A Story of Vigilance and Hope

The Precision Revolution: Navigating the Risk of Breast Cancer Recurrence Through Genomic Insights

• Patient Advocacy and Support

The Precision Revolution: Navigating the Risk of Breast Cancer Recurrence Through Genomic Insights

Nila Kartika Wati July 17, 2026

The moment a patient hears the words, “You have breast cancer,” the world undergoes an instantaneous and...

Read More Read more about The Precision Revolution: Navigating the Risk of Breast Cancer Recurrence Through Genomic Insights

Bridging the Gap: METAvivor Joins Coalition to Champion the Clinical Trial Modernization Act

• Metastatic Breast Cancer Research

Bridging the Gap: METAvivor Joins Coalition to Champion the Clinical Trial Modernization Act

Nila Kartika Wati July 17, 2026

In a significant move aimed at dismantling the systemic hurdles that have long hampered medical research, the...

Read More Read more about Bridging the Gap: METAvivor Joins Coalition to Champion the Clinical Trial Modernization Act

Bridging the Genomic Divide: How ‘GeNotes’ is Revolutionizing Clinical Practice

• Genomics and Precision Medicine

Bridging the Genomic Divide: How ‘GeNotes’ is Revolutionizing Clinical Practice

Nila Kartika Wati July 17, 2026

The integration of genomics into routine clinical care represents one of the most significant shifts in modern...

Read More Read more about Bridging the Genomic Divide: How ‘GeNotes’ is Revolutionizing Clinical Practice

Merck’s Lipfendra Approval: A New Era for Cholesterol Management and a Litmus Test for FDA Reform

• Chemotherapy and Targeted Therapy

Merck’s Lipfendra Approval: A New Era for Cholesterol Management and a Litmus Test for FDA Reform

Nila Kartika Wati July 17, 2026

In a landmark decision that could reshape the landscape of cardiovascular health, the U.S. Food and Drug...

Read More Read more about Merck’s Lipfendra Approval: A New Era for Cholesterol Management and a Litmus Test for FDA Reform